After Regaining Outreach, Lab Grows it by $10M

By Janette Wider | From the Volume XXXII, No. 14 – October 6, 2025 Issue

CEO SUMMARY: In this case study, Kootenai Health in Idaho explains how taking back lab outreach services from a commercial lab company can improve physician satisfaction, enhance patient care, and increase revenue. Although the transition was bumpy, within two years of bri…

Read More

---

National Lab Company Briefs

By Scott Wallask | From the Volume XXXII, No. 14 – October 6, 2025 Issue

Quest, Labcorp Push Alzheimer’s Test Quest Diagnostics and Labcorp are now offering Fujirebio’s Lumipulse test, the first Food and Drug Administration-cleared blood-based assay for con…

Read More

---

Internet Tracking Lawsuits Target Quest and Labcorp

By Robert Michel | From the Volume XXXI No. 15 – November 4, 2024 Issue

CEO SUMMARY: Here is the clinical lab industry’s first intelligence briefing on how class action attorneys are filing lawsuits against healthcare providers—including clinical laboratories. The allegations are that providers are using internet tracking tools, such as those offered by M…

Read More

---

FDA Issues Memo to Reclassify Many High Risk IVD Assays

By Robert Michel | From the Volume XXXI, No. 5 – April 8, 2024 Issue

WAS IT AN EXPECTED FLOOD OF APPLICATIONS TO REVIEW laboratory de…

Read More

---

Layoffs at Major Health Plans Slow Processing of Lab Claims

By Virchow | From the Volume XXXI, Number 1 – January 16, 2024 Issue

…

Read More

---

Violating EKRA Earns Lab Owner an Eight-Year Prison Sentence

By Robert Michel | From the Volume XXX, Number 18 – December 26, 2023 Issue

THIS MAY BE THE MOST HIGH-PROFILE CASE involving a clinical laboratory and the Eliminating Kickbacks in Recovery Act of 2018 (EKRA). Former Arrayit Corporation president Mark Schena was sentenced in October 2023 to eight years in federal prison and ordered to pay $24 million in resti…

Read More

---